BRIEF published on 10/01/2024 at 07:05, 2 months 20 days ago Advicenne progresse aux États-Unis avec des avis positifs de la FDA sur ADV7103 FDA Advicenne ADV7103 ATRd Cystinurie
BRIEF published on 10/01/2024 at 07:05, 2 months 20 days ago Advicenne Advances in US with Positive FDA Reviews for ADV7103 FDA ADV7103 ATRd Advicenna Cystinuria
PRESS RELEASE published on 10/01/2024 at 07:00, 2 months 20 days ago Informations privilégiées / Autres communiqués Advicenne franchit des étapes majeures aux Etats-Unis pour ADV7103 avec des avis favorables de la FDA, ouvrant des opportunités partenariales, simplifiant les démarches réglementaires et cliniques FDA Développement États-Unis Partenaires Advicenne
PRESS RELEASE published on 10/01/2024 at 07:00, 2 months 20 days ago Inside Information / Other news releases Advicenne achieves major milestones in the US with positive FDA opinions on ADV7103, accelerating partnership outlook for commercialization, preparing for clinical development in cystinuria, and seeking commercial partners Commercialization Advicenne ADV7103 Cystinuria FDA Opinions
BRIEF published on 05/15/2024 at 09:07, 7 months 6 days ago Advicenne Shareholders Approve Board-Supported Resolutions at General Meeting Euronext Growth Paris Pharmaceutical Industry General Meeting Advicenne Rare Renal Diseases
BRIEF published on 05/15/2024 at 09:07, 7 months 6 days ago Les actionnaires d'Advicenne approuvent les résolutions soutenues par le conseil d'administration lors de l'assemblée générale Assemblée Générale Euronext Croissance Paris Industrie Pharmaceutique Conseille Maladies Rénales Rares
PRESS RELEASE published on 05/15/2024 at 09:02, 7 months 6 days ago Inside Information / Other news releases Advicenne's Board of Directors' resolutions approved at the Combined General Meeting. Shareholders support all resolutions including financial statements and delegations Board Of Directors Shareholders Financial Statements Combined General Meeting Advicenne
BRIEF published on 05/15/2024 at 08:06, 7 months 6 days ago Advicenne lance un programme de rachat d'actions Marché Financier Rachat D'actions Euronext Growth Advicenne Maladies Rénales
BRIEF published on 05/15/2024 at 08:06, 7 months 6 days ago Advicenne launches a share buyback program Share Buyback Euronext Growth Financial Market Advicenne Kidney Diseases
PRESS RELEASE published on 05/15/2024 at 08:01, 7 months 6 days ago Informations privilégiées / Autres communiqués Advicenne annonce un programme de rachat d'actions autorisé par son assemblée générale mixte. Le programme permet l'achat de jusqu'à 10% du capital social avec un prix maximum de 21 euros par action Rachat D'actions Euronext Growth Programme Autorisation Advicenne
Published on 12/21/2024 at 01:30, 14 hours 35 minutes ago Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 14 hours 35 minutes ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 16 hours ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/20/2024 at 23:30, 16 hours 35 minutes ago Boron One Announces Extension to Early Warrant Exercise Incentive Program
Published on 12/21/2024 at 00:51, 15 hours 14 minutes ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 15 hours 20 minutes ago EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 20 hours 54 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 21 hours 9 minutes ago CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 22 hours 5 minutes ago ARYZTA AG Announces New Board Technology Committee
Published on 12/21/2024 at 12:17, 3 hours 47 minutes ago AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 3 hours 47 minutes ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 22 hours 5 minutes ago Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 22 hours 5 minutes ago Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 22 hours 10 minutes ago Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024
